© 2020 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2020 MJH Life Sciences™ and Formulary Watch. All rights reserved.
February 11, 2020
FDA cleared the first generic sodium iodide product to treat hyperthyroidism and carcinoma of the thyroid.
September 16, 2019
FDA is evaluating risks to patients.
August 02, 2019
FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).
June 17, 2019
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
January 28, 2019
FDA approves cabozantinib to treat patients with hepatocellular carcinoma, a community in need of new therapeutic options.
December 18, 2018
A new non-small cell lung cancer (NSCLC) treatment is available to healthcare providers immediately.
December 04, 2018
Here are the top 2 novel cancer drugs cleared by the agency.
October 01, 2018
Here are the top 3 new approvals from FDA.
July 16, 2018
FDA’s approval of an expanded indication for a prostate cancer drug could net 2 pharmaceutical manufacturers billions of dollars.
Pharma makers are voluntarily recalling several drugs containing this active ingredient, used to treat high blood pressure and heart failure, since they may contain a carcinogen.